Pharma small molecule discovery has continued its longtime inexorable decline noted some time ago in this paper. There is little doubt...

It’s long been known that better early prediction of drug-like compound properties overcomes costly drug attrition later. But prediction...

Everyone knows that off-targets are the bane of a drug developers existence, but surprisingly little has been done to address the...